Diagnostic Markers of Genitourinary Tumors
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Pathology and Molecular Diagnostics".
Deadline for manuscript submissions: 31 December 2024 | Viewed by 44
Special Issue Editors
Interests: genitourinary pathology; diagnostic biomarkers; prognostic/predictive biomarkers; digital pathology; emolymphopathology; bladder cancer; prostate cancer
Special Issues, Collections and Topics in MDPI journals
Interests: prostate cancer; bladder cancer; renal cell carcinoma; carcinogenesis; diagnosis; upper urinary tract tumors; treatment
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This Special Issue, entitled "Diagnostic Markers of Genitourinary Tumors," aims to explore the latest advancements in the field of diagnostic markers for genitourinary (GU) tumors and their application in routine practice. Genitourinary cancers, including those affecting the bladder, kidneys, prostate, and testes, present significant challenges in both diagnosis and treatment. This SI will focus on novel biomarkers, imaging techniques, molecular assays, and other diagnostic tools that allow early detection, refine prognostication, and tailor personalized treatment strategies for GU tumors, with a particular interest in immunohistochemistry, electron microscopy, in situ hybridization, DNA- and RNA-based techniques, and proteomics. By highlighting cutting-edge research and clinical applications, this Special Issue aims to advance the field of GU oncology, ultimately enhancing patient care and outcomes. In this setting, we look forward to receiving high-quality original articles, reviews, and case reports/case series. Papers dealing with the application of digital imaging systems and artificial intelligence to the field of diagnostics are particularly welcome.
Dr. Francesca Sanguedolce
Dr. Roberta Mazzucchelli
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- genitourinary tumors
- diagnostic markers
- biomarkers
- molecular diagnostics
- personalized medicine
